Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Forecasted

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) – Equities research analysts at Cantor Fitzgerald boosted their FY2024 earnings per share (EPS) estimates for Harmony Biosciences in a research report issued to clients and investors on Wednesday, November 1st. Cantor Fitzgerald analyst C. Duncan now forecasts that the company will post earnings per share of […]

Related Keywords

United States , China , Piper Sandler , Raymond James , Cantor Fitzgerald , Goldman Sachs Group , Platinum Investment Management Ltd , China Universal Asset Management Co , Life Insurance Co , Lazard Asset Management , Harmony Biosciences Holdings Inc , Berenberg Bank , Nasdaq , Harmony Biosciences Company Profile , Quadrant Capital Group , Harmony Biosciences Holdings , Free Report , Harmony Biosciences , Harmony Bioscience , Get Free Report , Capital Group , Investment Management , Universal Asset Management , Asset Management , Biosciences Holdings , Harmony Biosciences Daily , Nasdaq Hrmy , Thrmy , Medical , Earnings Estimates ,